Patients with MPN often exhibit elevated levels of pro-inflammatory cytokines, chemokines, and growth factors such as IL-1β, IL-6, IL-8, IL-10, TNF-α, and TGF-β in the bone marrow microenvironment and peripheral blood [8,9,10]. Here, IL6 is linked to myeloproliferative disorder.